Track Omada Health — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Omada Health OMDA · Stock Open Omada Health in new tab

20.51 USD
EPS
-0.23
P/B
5.17
ROE
-4.30
Target Price
24.58 USD
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
EPS-0.23
Book Value3.95
Price to Book5.17
Debt/Equity13.99
% Insiders2.182%
Growth
Revenue Growth0.42%
Estimates
Forward P/E43.12
Forward EPS0.47
Target Mean Price24.58

DCF Valuation

Tweak assumptions to recompute fair value for Omada Health (OMDA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Omada Health Logo Omada Health Analysis (OMDA)

Is Omada Health a good investment? Omada Health (OMDA) is currently trading at 20.51 USD. Market analysts have a consensus price target of 24.58 USD. This suggests a potential upside from current levels.

Earnings Schedule: Omada Health is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 0.47.

Investor FAQ

Does Omada Health pay a dividend?

No, it does not currently pay a dividend.

What asset class is Omada Health?

Omada Health is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -0.23.

Company Profile

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion